Background & Sources: Medical literature on Reglan associated Tardive Dyskinesia risk

A curated reading list of authoritative medical research, drug-safety databases, and focused analysis for researchers, patients, and advocates.

Primary topic reference

Medical literature on Reglan associated Tardive Dyskinesia risk: A Detailed Overview — detailed background and analysis.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

National Institutes of Health (NIH)

Reference: National Institutes of Health (NIH)

Authoritative source for clinical, regulatory, and public-health background reading.